TABLE 1. LIST OF 3D PRINTED DRUGS DEVELOPED BY APRECIA PHARMACEUTICALS APPROVED BY FDA
TABLE 2. GLOBAL 3D PRINTED DRUGS MARKET FOR SPRITAM, BY GEOGRAPHY, 2017-2023 ($MILLION)
TABLE 3. OTHER 3D PRINTED DRUGS POTENTIAL MARKET, BY SCENARIO, 2020-2030 ($MILLION)
TABLE 4. OTHER 3D PRINTED DRUGS POTENTIAL MARKET, BY LOW GROWTH SCENARIO, BY REGION, 2020-2030, ($MILLION)
TABLE 5. OTHER 3D PRINTED DRUGS POTENTIAL MARKET, BY MODERATE GROWTH SCENARIO, BY REGION, 2020-2030, ($MILLION)
TABLE 6. OTHER 3D PRINTED DRUGS POTENTIAL MARKET, BY HIGH GROWTH SCENARIO, BY REGION, 2020-2030, ($MILLION)
TABLE 7. NORTH AMERICA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 8. NORTH AMERICA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 9. NORTH AMERICA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 10. EUROPE OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 11. EUROPE OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 12. EUROPE OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 13. ASIA-PACIFIC OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 14. ASIA-PACIFIC OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 15. ASIA-PACIFIC OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 16. LAMEA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 17. LAMEA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 18. LAMEA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, HIGH GROWTH SCENARIO, BY COUNTRY, 2020-2030, ($MILLION)
TABLE 19. APRECIA PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 20. APRECIA PHARMACEUTICALS: OPERATING SEGMENT
TABLE 21. FABRX: COMPANY SNAPSHOT
TABLE 22. FABRX: PRODUCT SEGMENT
TABLE 23. GSK: COMPANY SNAPSHOT
TABLE 24. GSK: OPERATING SEGMENTS

LIST OF FIGURE

FIGURE 1. PREVALENCE OF DYSPHAGIA ASSOCIATED WITH VARIOUS DIORDERS, 2008 (IN PERCENTAGE)
FIGURE 2. IMPACT ANALYSIS, 2017
FIGURE 3. U.S. 3D PRINTED DRUGS MARKET FOR SPRITAM, 2017-2023 ($MILLION)
FIGURE 4. REST OF WORLD 3D PRINTED DRUGS MARKET FOR SPRITAM, 2017-2023 ($MILLION)
FIGURE 5. OTHER 3D PRINTED DRUGS POTENTIAL MARKET, BY LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 6. OTHER 3D PRINTED DRUGS POTENTIAL MARKET, BY MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 7. OTHER 3D PRINTED DRUGS POTENTIAL MARKET, BY HIGH GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 8. OTHER 3D PRINTED DRUGS POTENTIAL MARKET, SHARE BY REGION, 2020 (%)
FIGURE 9. U.S. OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 10. U.S. OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 11. U.S. OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 12. REST OF NORTH AMERICA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 13. REST OF NORTH AMERICA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 14. REST OF NORTH AMERICA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 15. UK OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 16. UK OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 17. UK OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 18. GERMANY OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 19. GERMANY OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 20. GERMANY OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 21. FRANCE OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 22. FRANCE OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 23. FRANCE OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 24. ITALY OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 25. ITALY OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 26. ITALY OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 27. SPAIN OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 28. SPAIN OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 29. SPAIN OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 30. REST OF EUROPE OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 31. REST OF EUROPE OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 32. REST OF EUROPE OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 33. JAPAN OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 34. JAPAN OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 35. JAPAN OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 36. CHINA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 37. CHINA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 38. CHINA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 39. AUSTRALIA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 40. AUSTRALIA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 41. AUSTRALIA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 42. REST OF ASIA-PACIFIC OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 43. REST OF ASIA-PACIFIC OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 44. REST OF ASIA-PACIFIC OTHER 3D PRINTED DRUGS POTENTIAL MARKET, RAPID GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 45. BRAZIL OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 46. BRAZIL OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 47. BRAZIL OTHER 3D PRINTED DRUGS POTENTIAL MARKET, HIGH GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 48. SAUDI ARABIA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 49. SAUDI ARABIA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 50. SAUDI ARABIA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, HIGH GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 51. REST OF LAMEA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, LOW GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 52. REST OF LAMEA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, MODERATE GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 53. REST OF LAMEA OTHER 3D PRINTED DRUGS POTENTIAL MARKET, HIGH GROWTH SCENARIO, 2020-2030 ($MILLION)
FIGURE 54. GSK: REVENUE, 2014-2016 ($MILLION)
FIGURE 55. GSK: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 56. GSK: REVENUE SHARE BY GEOGRAPHY, 2016 (%)